» Articles » PMID: 7876145

Stimulation of Phospholipase D by Epidermal Growth Factor Requires Protein Kinase C Activation in Swiss 3T3 Cells

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1995 Feb 24
PMID 7876145
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The proposal that epidermal growth factor (EGF) activates phospholipase D (PLD) by a mechanism(s) not involving phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) hydrolysis was examined in Swiss 3T3 fibroblasts. EGF, basic fibroblast growth factor (bFGF), bombesin, and platelet-derived growth factor (PDGF) activated PLD as measured by transphosphatidylation of butanol to phosphatidylbutanol. The increase in inositol phosphates induced by bFGF, EGF, or bombesin was significantly enhanced by Ro-31-8220, an inhibitor of protein kinase C (PKC), suggesting that PtdIns(4,5)P2-hydrolyzing phospholipase is coupled to the receptors for these agonists but that the response is down-regulated by PKC. Activation of PLD by EGF was inhibited dose dependently by the PKC inhibitors bis-indolylmaleimide and Ro-31-8220, which also inhibited the effects of bFGF, bombesin, and PDGF. Down-regulation of PKC by prolonged treatment with 4 beta-phorbol 12-myristate 13-acetate also abolished EGF- and PDGF-stimulated phosphatidylbutanol formation. EGF and bombesin induced biphasic translocations of PKC delta and epsilon to the membrane that were detectable at 15 s. In the presence of Ro-31-8220, translocation of PKC alpha became evident, and membrane association of the delta- and epsilon-isozymes was enhanced and/or sustained in response to the two agonists. The inhibitor also enhanced EGF-stimulated [3H]diacylglycerol formation in cells preincubated with [3H]arachidonic acid, which labeled predominantly phosphatidylinositol, but inhibited [3H]diacylglycerol production in cells preincubated with [3H]myristic acid, which labeled mainly phosphatidylcholine. These data support the conclusion that EGF can stimulate diacylglycerol formation from PtdIns(4,5)P2 and that PKC performs the dual role of down-regulating this response as well as mediating phosphatidylcholine hydrolysis. In summary, all of the results of the study indicate that PLD activation by EGF is downstream of PtdIns(4,5)P2-hydrolyzing phospholipase and is dependent upon subsequent PKC activation.

Citing Articles

An intrinsic lipid-binding interface controls sphingosine kinase 1 function.

Pulkoski-Gross M, Jenkins M, Truman J, Salama M, Clarke C, Burke J J Lipid Res. 2018; 59(3):462-474.

PMID: 29326159 PMC: 5832922. DOI: 10.1194/jlr.M081307.


Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Bruntz R, Lindsley C, Brown H Pharmacol Rev. 2014; 66(4):1033-79.

PMID: 25244928 PMC: 4180337. DOI: 10.1124/pr.114.009217.


Intracellular Ca2+ oscillations generated via the Ca2+-sensing receptor are mediated by negative feedback by PKCα at Thr888.

Young S, Rey O, Sinnett-Smith J, Rozengurt E Am J Physiol Cell Physiol. 2013; 306(3):C298-306.

PMID: 24336654 PMC: 3919994. DOI: 10.1152/ajpcell.00194.2013.


Cell invasion of highly metastatic MTLn3 cancer cells is dependent on phospholipase D2 (PLD2) and Janus kinase 3 (JAK3).

Henkels K, Farkaly T, Mahankali M, Segall J, Gomez-Cambronero J J Mol Biol. 2011; 408(5):850-62.

PMID: 21414324 PMC: 3081905. DOI: 10.1016/j.jmb.2011.03.017.


Therapeutic levels of the hydroxmethylglutaryl-coenzyme A reductase inhibitor lovastatin activate ras signaling via phospholipase D2.

Cho K, Hill M, Chigurupati S, Du G, Parton R, Hancock J Mol Cell Biol. 2011; 31(6):1110-20.

PMID: 21245384 PMC: 3067913. DOI: 10.1128/MCB.00989-10.